vs
Side-by-side financial comparison of Marathon Bancorp, Inc. (MBBC) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
Marathon Bancorp, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.4M, roughly 1.6× PLUS THERAPEUTICS, INC.). Marathon Bancorp, Inc. runs the higher net margin — 22.3% vs -417.9%, a 440.2% gap on every dollar of revenue. On growth, Marathon Bancorp, Inc. posted the faster year-over-year revenue change (41.7% vs -3.2%). Marathon Bancorp, Inc. produced more free cash flow last quarter ($1.4M vs $-6.3M). Over the past eight quarters, Marathon Bancorp, Inc.'s revenue compounded faster (20.3% CAGR vs -9.7%).
Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
MBBC vs PSTV — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2M | $1.4M |
| Net Profit | $501.4K | $-5.7M |
| Gross Margin | — | — |
| Operating Margin | 26.2% | -420.0% |
| Net Margin | 22.3% | -417.9% |
| Revenue YoY | 41.7% | -3.2% |
| Net Profit YoY | 880.7% | -46.4% |
| EPS (diluted) | $0.19 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2M | $1.4M | ||
| Q3 25 | $2.1M | $1.4M | ||
| Q2 25 | $1.9M | $1.4M | ||
| Q1 25 | $1.7M | $1.1M | ||
| Q4 24 | $1.6M | $1.4M | ||
| Q3 24 | $1.6M | $1.5M | ||
| Q2 24 | $1.6M | $1.3M | ||
| Q1 24 | $1.6M | $1.7M |
| Q4 25 | $501.4K | $-5.7M | ||
| Q3 25 | $444.3K | $-4.4M | ||
| Q2 25 | $-332.0K | $5.2M | ||
| Q1 25 | $148.4K | $-17.4M | ||
| Q4 24 | $51.1K | $-3.9M | ||
| Q3 24 | $174.9K | $-2.9M | ||
| Q2 24 | $85.8K | $-2.9M | ||
| Q1 24 | $-631.1K | $-3.3M |
| Q4 25 | 26.2% | -420.0% | ||
| Q3 25 | 25.5% | -320.8% | ||
| Q2 25 | -25.7% | -110.6% | ||
| Q1 25 | 11.6% | -333.9% | ||
| Q4 24 | 3.3% | -276.2% | ||
| Q3 24 | 13.4% | -260.9% | ||
| Q2 24 | 4.1% | -289.1% | ||
| Q1 24 | -53.7% | -196.7% |
| Q4 25 | 22.3% | -417.9% | ||
| Q3 25 | 20.7% | -316.6% | ||
| Q2 25 | -18.9% | 370.6% | ||
| Q1 25 | 8.9% | -1643.2% | ||
| Q4 24 | 3.2% | -276.4% | ||
| Q3 24 | 10.8% | -197.4% | ||
| Q2 24 | 6.2% | -229.9% | ||
| Q1 24 | -40.7% | -194.5% |
| Q4 25 | $0.19 | $0.95 | ||
| Q3 25 | $0.17 | $-0.04 | ||
| Q2 25 | $-0.13 | $-0.01 | ||
| Q1 25 | $0.07 | $-1.19 | ||
| Q4 24 | $0.02 | $-0.51 | ||
| Q3 24 | $0.06 | $-0.37 | ||
| Q2 24 | $0.07 | $-0.71 | ||
| Q1 24 | $-0.31 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.9M | $4.0M |
| Total Assets | $248.0M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | — | $9.9M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | $46.9M | $4.0M | ||
| Q3 25 | $46.3M | $5.1M | ||
| Q2 25 | $45.7M | $3.0M | ||
| Q1 25 | $32.0M | $-23.6M | ||
| Q4 24 | $31.7M | $-8.9M | ||
| Q3 24 | $31.6M | $-5.2M | ||
| Q2 24 | $31.3M | $-7.6M | ||
| Q1 24 | $31.4M | $-4.8M |
| Q4 25 | $248.0M | $16.3M | ||
| Q3 25 | $246.0M | $18.7M | ||
| Q2 25 | $238.8M | $10.3M | ||
| Q1 25 | $236.8M | $12.1M | ||
| Q4 24 | $217.9M | $6.6M | ||
| Q3 24 | $216.5M | $7.0M | ||
| Q2 24 | $219.3M | $11.2M | ||
| Q1 24 | $225.8M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $-6.3M |
| Free Cash FlowOCF − Capex | $1.4M | $-6.3M |
| FCF MarginFCF / Revenue | 62.3% | -459.9% |
| Capex IntensityCapex / Revenue | 0.6% | 2.2% |
| Cash ConversionOCF / Net Profit | 2.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $-6.3M | ||
| Q3 25 | $464.0K | $-2.5M | ||
| Q2 25 | $1.4M | $-5.8M | ||
| Q1 25 | $849.0K | $-6.2M | ||
| Q4 24 | $113.6K | $-1.2M | ||
| Q3 24 | $945.2K | $-3.7M | ||
| Q2 24 | $416.6K | $-1.1M | ||
| Q1 24 | $-802.1K | $-4.5M |
| Q4 25 | $1.4M | $-6.3M | ||
| Q3 25 | $456.6K | $-2.6M | ||
| Q2 25 | $1.3M | $-5.8M | ||
| Q1 25 | $773.2K | $-6.2M | ||
| Q4 24 | $105.0K | $-1.2M | ||
| Q3 24 | $921.6K | $-3.7M | ||
| Q2 24 | $-1.8M | $-1.2M | ||
| Q1 24 | $-1.1M | $-4.6M |
| Q4 25 | 62.3% | -459.9% | ||
| Q3 25 | 21.3% | -184.3% | ||
| Q2 25 | 66.0% | -417.6% | ||
| Q1 25 | 46.3% | -583.1% | ||
| Q4 24 | 6.6% | -86.5% | ||
| Q3 24 | 57.1% | -253.7% | ||
| Q2 24 | -118.5% | -96.2% | ||
| Q1 24 | -67.9% | -271.5% |
| Q4 25 | 0.6% | 2.2% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 9.3% | 0.5% | ||
| Q1 25 | 4.5% | 0.3% | ||
| Q4 24 | 0.5% | 0.8% | ||
| Q3 24 | 1.5% | 1.0% | ||
| Q2 24 | 145.2% | 6.3% | ||
| Q1 24 | 16.2% | 2.4% |
| Q4 25 | 2.82× | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | 5.72× | — | ||
| Q4 24 | 2.22× | — | ||
| Q3 24 | 5.40× | — | ||
| Q2 24 | 4.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
